BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31937902)

  • 21. Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
    de Kock L; Sabbaghian N; Soglio DB; Guillerman RP; Park BK; Chami R; Deal CL; Priest JR; Foulkes WD
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1072-7. PubMed ID: 24617712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas: Molecular Characterization and Proposal for a Separate Classification.
    Rooper LM; Bynum JP; Miller KP; Lin MT; Gagan J; Thompson LDR; Bishop JA
    Am J Surg Pathol; 2020 Jun; 44(6):826-833. PubMed ID: 31917706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic Profiling of Aggressive Thyroid Cancer in Association With its Clinicopathological Characteristics.
    Kim JH; Jeong JY; Seo AN; Park NJ; Kim M; Park JY
    In Vivo; 2022; 36(1):111-120. PubMed ID: 34972706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology.
    Chong AS; Nikiforov YE; Condello V; Wald AI; Nikiforova MN; Foulkes WD; Rivera B
    J Clin Endocrinol Metab; 2021 Mar; 106(4):968-977. PubMed ID: 33460435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature.
    Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
    Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A complex DICER1 syndrome phenotype associated with a germline pathogenic variant affecting the RNase IIIa domain of DICER1.
    Pontén E; Frisk S; Taylan F; Vaz R; Wessman S; de Kock L; Pal N; Foulkes WD; Lagerstedt-Robinson K; Nordgren A
    J Med Genet; 2022 Feb; 59(2):141-146. PubMed ID: 33208384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic DICER1 Mutations in a Pubertal Girl with Cervical Embryonal Rhabdomyosarcoma and Papillary Thyroid Adenoma.
    Zhang L; Ye H; Jin Y; Zhong P; Duan H
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):742-744. PubMed ID: 32682898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
    Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
    J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
    Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
    Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of DICER 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
    Lee M; Kim TI; Jang SJ; Cho KJ; Lee SM; Kim HR; Song JS
    Pathobiology; 2021; 88(3):251-260. PubMed ID: 33567437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multinodular Goiter Progression Toward Malignancy in a Case of DICER1 Syndrome: Histologic and Molecular Alterations.
    Gullo I; Batista R; Rodrigues-Pereira P; Soares P; Barroca H; do Bom-Sucesso M; Sobrinho-Simões M
    Am J Clin Pathol; 2018 Mar; 149(5):379-386. PubMed ID: 29538609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
    Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of DICER1 variants in large multinodular goiter: thyroid function, clinical and imaging characteristics.
    Cabral Miranda LJ; Danilovic DLS; Vanderlei FAB; Tavares MR; Neto NL; Asato de Camargo RY; Marui S
    Arch Endocrinol Metab; 2024 Feb; 68():e230030. PubMed ID: 38330293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
    Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
    J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome.
    de Kock L; Wang YC; Revil T; Badescu D; Rivera B; Sabbaghian N; Wu M; Weber E; Sandoval C; Hopman SM; Merks JH; van Hagen JM; Bouts AH; Plager DA; Ramasubramanian A; Forsmark L; Doyle KL; Toler T; Callahan J; Engelenberg C; Bouron-Dal Soglio D; Priest JR; Ragoussis J; Foulkes WD
    J Med Genet; 2016 Jan; 53(1):43-52. PubMed ID: 26475046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.